Literature DB >> 17502040

Neurologic manifestations of the antiphospholipid syndrome.

Jose F Roldan1, Robin L Brey.   

Abstract

Antiphospholipid syndrome is an important cause of neurologic morbidity. The clinical criteria for antiphospholipid syndrome include only cerebrovascular arterial and venous thrombosis, but many other neurologic manifestations have been associated with antiphospholipid antibodies (aPL). This review discusses the role of aPL in cerebrovascular manifestations and in some of the other neurologic manifestations commonly associated with these antibodies, as well as data pertaining to the pathophysiology of aPL-associated neurologic manifestations and treatment issues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502040     DOI: 10.1007/s11926-007-0004-3

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  49 in total

1.  Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement-a preliminary report.

Authors:  S S Sun; F Y Liu; J J P Tsai; R F Yen; C H Kao; W S Huang
Journal:  Rheumatol Int       Date:  2003-04-09       Impact factor: 2.631

2.  Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study.

Authors:  G E Tietjen; M Day; L Norris; S Aurora; A Halvorsen; L R Schultz; S R Levine
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

3.  Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus.

Authors:  M Sailer; W Burchert; C Ehrenheim; H G Smid; J Haas; K Wildhagen; U Wurster; H Deicher
Journal:  J Neurol       Date:  1997-03       Impact factor: 4.849

Review 4.  Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies.

Authors:  Silvia S Pierangeli; Mariano Vega-Ostertag; E Nigel Harris
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

Review 5.  Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology.

Authors:  Giovanni Sanna; Maria Laura Bertolaccini; Graham R V Hughes
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 6.  Antiphospholipid antibodies in an in vivo thrombosis model in mice.

Authors:  S S Pierangeli; E N Harris
Journal:  Lupus       Date:  1994-08       Impact factor: 2.911

7.  Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus.

Authors:  J Montalbán; R Cervera; J Font; J Ordi; J Vianna; H J Haga; M Tintoré; M A Khamashta; G R Hughes
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

8.  Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.

Authors:  Steven R Levine; Robin L Brey; Barbara C Tilley; J L P Thompson; Ralph L Sacco; Robert R Sciacca; A Murphy; Yimeng Lu; Teresa M Costigan; Candi Rhine; Bruce Levin; Douglas A Triplett; J P Mohr
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

9.  Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus.

Authors:  E Toubi; M A Khamashta; A Panarra; G R Hughes
Journal:  Am J Med       Date:  1995-10       Impact factor: 4.965

10.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

View more
  5 in total

Review 1.  A model for lupus brain disease.

Authors:  Betty Diamond; Bruce T Volpe
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Neuropsychiatric systemic lupus erythematosus reconsidered.

Authors:  Jorge Sánchez-Guerrero; Cynthia Aranow; Meggan Mackay; Bruce Volpe; Betty Diamond
Journal:  Nat Clin Pract Rheumatol       Date:  2008-03

Review 3.  Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy.

Authors:  Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

Review 4.  Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical management.

Authors:  Pasquale Pignatelli; Evaristo Ettorre; Danilo Menichelli; Arianna Pani; Francesco Violi; Daniele Pastori
Journal:  Haematologica       Date:  2020-01-30       Impact factor: 9.941

5.  Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers.

Authors:  Ting-Syuan Lin; Pei-Ying Hsu; Chin-Hao Chang; Chi-Lun Ko; Yu-Min Kuo; Yen-Wen Wu; Ruoh-Fang Yen; Cheng-Han Wu; Ko-Jen Li; Yenh-Chen Hsein; Song-Chou Hsieh
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.